Source:http://linkedlifedata.com/resource/pubmed/id/12520099
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2003-1-9
|
pubmed:abstractText |
Meq is one of the candidate oncogenes in the MDV1 genome. We previously reported a difference in the meq open reading frame (ORF) between oncogenic and non-oncogenic MDV1: L-meq, in which a 180-bp sequence is inserted into the meq ORF, is detected in non-oncogenic MDV1. To study the functions of a gene product of L-meq (L-MEQ), transactivation by L-MEQ was analyzed by dual luciferase assay using a reporter gene under the control of long (-1--873 bp) and short (-1 - -355 bp) meq promoter (LMP and SMP, respectively). LMP showed higher promoter function than SMP. L-MEQ transactivated the expression of the reporter gene, but less than MEQ did. In the presence of SMP or the cytomegalovirus immediate-early promoter, the same or slightly higher transactivation was observed in cells cotransfected with both meq and L-meq than cells transfected only with meq. However, in the presence of LMP, lower transactivation was observed in cells cotransfected with both meq and L-meq than cells transfected only with meq, suggesting that L-MEQ can be a transrepressor. Replication of a vvMDV1 was enhanced in the cells with meq. Interestingly, however, replication of vvMDV1 was suppressed in the cells with L-meq or with both L-meq and meq, compared to untransfected cells. Thus, L-MEQ could suppress replication of vvMDV1 displaying the meq gene in coinfected cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0916-7250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1091-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12520099-Animals,
pubmed-meshheading:12520099-Antiviral Agents,
pubmed-meshheading:12520099-Cells, Cultured,
pubmed-meshheading:12520099-Gene Expression Regulation, Viral,
pubmed-meshheading:12520099-Herpesvirus 2, Gallid,
pubmed-meshheading:12520099-Humans,
pubmed-meshheading:12520099-Mice,
pubmed-meshheading:12520099-Oncogene Proteins, Viral,
pubmed-meshheading:12520099-Promoter Regions, Genetic,
pubmed-meshheading:12520099-Transcription, Genetic,
pubmed-meshheading:12520099-Transcriptional Activation,
pubmed-meshheading:12520099-Tumor Cells, Cultured,
pubmed-meshheading:12520099-Virus Replication
|
pubmed:year |
2002
|
pubmed:articleTitle |
Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1.
|
pubmed:affiliation |
Department of Disease Control, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
|
pubmed:publicationType |
Journal Article
|